• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100071
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Hematoma (1884)
Event Type  Injury  
Manufacturer Narrative
Investigation conclusion: it is indicated that the product is not returning for evaluation.As the patient did not provide a lot number of the product used, testing using reserve product from the same lot and a manufacturing review could not be conducted.No further investigation is possible at this time.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
 
Event Description
The patient began using the inratio system in or around 2005 and the inratio2 system in or around 2009.On approximately (b)(6) 2010, the patient recalled receiving a "normal" inratio inr result.The actual result received and the patient's therapeutic range was not provided.On or around (b)(6) 2010, the patient believed she was having a stroke and was admitted to the hospital.During the hospitalization, the patient was diagnosed with a subdural hematoma.No information on laboratory inr testing or treatment provided available.Following the hospitalization, the patient was taken off coumadin, and no longer used the inratio system.No additional information was provided.
 
Manufacturer Narrative
Additional information: (age at time of the event) was updated to include the patient's date of birth.(describe event or problem) was updated to include the patient's therapeutic range and historical result.(list of products and dates) was updated to include the serial number of the inratio monitor.(reported name and address) was updated to include the email address and address.
 
Event Description
The patient began using the inratio system in or around 2005 and the inratio2 system in or around 2009.On approximately september 12, 2010, the patient recalled receiving a "normal" inratio inr result.A review of records provided by alere home monitoring indicates the patient received an inr result of 2.8 on (b)(6) 2010.The patient's therapeutic range was 2.0 - 3.0.On or around (b)(6) 2010, the patient believed she was having a stroke and was admitted to the hospital.During the hospitalization, the patient was diagnosed with a subdural hematoma.No information on laboratory inr testing or treatment provided available.Following the hospitalization, the patient was taken off coumadin, and no longer used the inratio system.No additional information was provided.
 
Manufacturer Narrative
(describe event or problem) updated to include information regarding medical records received 09/15/2017.
 
Event Description
The patient began using the inratio system in or around 2005 and the inratio2 system in or around 2009.On approximately (b)(6) 2010, the patient recalled receiving a "normal" inratio inr result.The actual result received and the patient's therapeutic range was not provided.On or around (b)(6) 2010, the patient believed she was having a stroke and was admitted to the hospital.During the hospitalization, the patient was diagnosed with a subdural hematoma.No information on laboratory inr testing or treatment provided available.Following the hospitalization, the patient was taken off coumadin, and no longer used the inratio system.No additional information was provided.On 09/15/2017, extensive medical records were received regarding this event.The medical records describe the same event and no new complaint is alleged.There is no reported information that would alter the initial mdr reporting decision or mdr filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC
9975 summers ridge road
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge road
san diego, CA 92121
8588052084
MDR Report Key6439877
MDR Text Key71049704
Report Number2027969-2017-00056
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Patient
Type of Report Initial,Followup,Followup
Report Date 02/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/28/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number100071
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received09/15/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
INRATIO2 MONITOR, PN 200432, SERIAL# UNKNOWN
Patient Outcome(s) Hospitalization;
-
-